These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8785983)

  • 1. Steps towards the development of a replacement in vitro test for quantification of antibodies to tetanus toxin during potency testing of vaccine.
    Southern J; Clements H; Spenceley L
    Dev Biol Stand; 1996; 86():343. PubMed ID: 8785983
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J; Akkermans A; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of tetanus antitoxin in human sera. II. Comparison of counter-immunoelectrophoresis and passive haemagglutination with toxin neutralization in mice.
    Winsnes R; Christiansen G
    Acta Pathol Microbiol Scand B; 1979 Jun; 87B(3):197-200. PubMed ID: 474133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive haemagglutination tests using purified antigens covalently coupled to turkey erythrocytes.
    Relyveld EH; Huet M; Lery L
    Dev Biol Stand; 1996; 86():225-41. PubMed ID: 8785953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use.
    Pharmeuropa Spec Issue Biol; 2002 Oct; 2001(2):1-92. PubMed ID: 11820120
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 1. Systems for the detection of in vitro synthetized specific immunoglobulins. Strategies of test development].
    Kiessig ST; Jahn S; Porstmann T; von Baehr R
    Allerg Immunol (Leipz); 1987; 33(2):79-87. PubMed ID: 2959129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U; Noeske K; Werner E
    ALTEX; 2005; 22(3):169-74. PubMed ID: 16186992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the in vitro toxin binding inhibition (ToBI) test for the estimation of the potency of tetanus toxoid.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    Biologicals; 1991 Jan; 19(1):23-9. PubMed ID: 2049173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of an in vitro endopeptidase assay for detection of residual toxin activity in tetanus toxoids.
    Leung T; Corran PH; Gee C; Ekong TA; Sesardic D
    Dev Biol (Basel); 2002; 111():327-32. PubMed ID: 12678257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical tetanus despite a protective level of toxin-neutralizing antibody.
    Passen EL; Andersen BR
    JAMA; 1986 Mar; 255(9):1171-3. PubMed ID: 2868135
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemagglutination antibody titre levels which give certain protection against tetanus toxin.
    Bistoni F; Marconi P; Tissi L; Bastianini L; Pitzurra M
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):590-5. PubMed ID: 755487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendriksen CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective toxoid from tetanus toxin prepared by stepwise iodination of purified toxin.
    Soares HR; Nunes RL; Prado SM; Higashi HG; Heneine IF
    Biologicals; 1994 Mar; 22(1):29-33. PubMed ID: 8068311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the toxin neutralization test in mice.
    Manghi MA; Pasetti MF; Brero ML; Deluchi S; di Paola G; Mathet V; Eriksson PV
    J Immunol Methods; 1994 Jan; 168(1):17-24. PubMed ID: 8288891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.